Skip to main navigation Skip to search Skip to main content

Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH)

  • Osamah Hussein
  • , Masha Grosovski
  • , Sorina Schlesinger
  • , Sergio Szvalb
  • , Nimer Assy

Research output: Contribution to journal › Article › peer-review

60 Scopus citations

Fingerprint

Dive into the research topics of 'Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science